why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: April 27, 2025

Clinical Trial: Sugammadex-Induced Clenching During Neuromuscular Blockade Reversal

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Neuromuscular Blockade Reversal Agent

Study Type: INTERVENTIONAL


Official Title: A Prospective, Randomized, Double-Blind Study of the Incidence, Severity, and Risk Factors of Clenching Induced by Sugammadex During Neuromuscular Blockade Reversal

Brief Summary: Study Objective:This study aims to evaluate the incidence, severity, and risk factors of sugammadex-induced mouth clenching during neuromuscular blockade (NMB) reversal in adult surgical patients.Study Design:This prospective, randomized, double-blind, controlled clinical trial enrolls adult patients (ASA physical status I-II, aged 19-70 years) undergoing elective surgery under general anesthesia with rocuronium.Patients will be randomized into four groups to receive either sugammadex at doses of 1 mg/kg, 2…

Read more